News

Celebrating a Legacy: ABC Fine Wine & Spirits Supports Children

Celebrating a Legacy: ABC Fine Wine & Spirits Supports Children

ABC Fine Wine & Spirits Renewed Commitment to Pediatric Cancer Research

For the 14th consecutive year, ABC Fine Wine & Spirits has partnered with the National Pediatric Cancer Foundation to support vital research aimed at combating childhood cancer. This esteemed Florida-based retailer, recognized as the largest family-owned wine and spirits provider, is dedicated to making a significant impact on the lives of children diagnosed with cancer.

Ways to Make a Difference

From a defined period, guests visiting any ABC Fine Wine & Spirits location can contribute to this noble cause in three impactful ways:

1. Donate at Checkout

Customers can round up their purchase or make a voluntary donation at the cash register during their shopping experience at any ABC store across the state.

2. Purchase Select Brands

By purchasing select brands such as Kim Crawford, Ruffino, Unshackled, and several others, customers automatically contribute a portion of the proceeds to the National Pediatric Cancer Foundation’s efforts to finance research for less toxic cancer treatments.

3. Direct Donations

Supporters can also choose to donate directly online at any time, helping to boost funding for crucial research initiatives that will lead to breakthroughs in treatment.

A Message of Hope

Dave Larue, Executive Vice President of Sales at ABC Fine Wine & Spirits, expressed the importance of this ongoing partnership, emphasizing that the campaign focuses not only on fundraising but also on fostering hope for families affected by childhood cancer. Last year alone, they were able to raise an impressive amount which contributed to a total exceeding two million dollars over the years.

Encouragement for Community Involvement

ABC Fine Wine & Spirits invites its customers and the broader community to participate actively in this campaign by contributing not just financially, but also in spreading awareness about the challenges faced by children battling cancer. The more people know, the more help can be provided.

Appreciation for Partnership

David Frazer, CEO of the National Pediatric Cancer Foundation, expressed deep gratitude for the continuous commitment shown by ABC Fine Wine & Spirits and Constellation Brands. Their long-standing collaboration serves as a beacon of hope, illustrating what can be accomplished when communities come together for a common good.

About ABC Fine Wine & Spirits

Founded in 1936, ABC Fine Wine & Spirits has a long history of serving its customers with quality products. With its headquarters based in Florida, the retailer operates 126 stores statewide, curating an impressive selection of wine, spirits, and gourmet food options for patrons.

About the National Pediatric Cancer Foundation

The National Pediatric Cancer Foundation is a recognized nonprofit organization committed to advancing research and clinical trials to find innovative treatments for childhood cancer. With a focus on reducing the side effects of current therapies and increasing survival rates, the NPCF collaborates with numerous hospitals and scientists to push forward its mission of enhancing the lives of affected children.

Frequently Asked Questions

1. How can I contribute to ABC Fine Wine & Spirits' fundraising efforts?

You can contribute by rounding up your purchase at checkout, purchasing select brands, or making a direct donation online.

2. What types of brands are included in the fundraising campaign?

Brands such as Kim Crawford, Ruffino, and The Prisoner among others participate, with a portion of the proceeds going to the National Pediatric Cancer Foundation.

3. How long has ABC Fine Wine & Spirits been supporting this cause?

ABC has been supporting the National Pediatric Cancer Foundation for 14 consecutive years, demonstrating their commitment to this important work.

4. Where can I find more information about the National Pediatric Cancer Foundation?

Additional information can be found on the website of ABC Fine Wine & Spirits or directly through the National Pediatric Cancer Foundation's resources.

5. What is the overarching goal of this partnership?

The primary goal is to raise awareness and funds to facilitate research into safer and more effective treatments for childhood cancer.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 198

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 206

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading

Top 5 Most Recently Viewed Articles

CJ BIO's Bold Steps for Sustainable Animal Nutrition

Updated Category News Views 558

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Continue Reading
ParaZero Technologies Achieves Nasdaq Compliance Milestone

Updated Category News Views 130

ParaZero Technologies Regains Compliance with Nasdaq Standards Recent developments in the aerospace sector have highlighted the impressive strides made by ParaZero Technologies Ltd. (Nasdaq: PRZO), an innovator in safety systems for drones and urban air mobility vehicles. The company has reached a significant milestone, regaining compliance with Nasdaq’s minimum bid...

Continue Reading
Revolutionizing Semiconductor Design with AI Integration

Updated Category News Views 389

Ricursive Intelligence Launches Groundbreaking AI Lab Ricursive Intelligence is setting a new standard in semiconductor design with the introduction of its innovative AI lab. This initiative aims to seamlessly blend artificial intelligence with chip creation to expedite progress within the tech landscape. Major Funding and Valuation Boost The company recently raised an...

Continue Reading
Craneware plc Publishes a Key Trading Disclosure Notice

Updated Category News Views 219

Introduction to Craneware plc's Trading Disclosure Craneware plc, a prominent player in the healthcare technology space, has officially announced a significant trading disclosure following the rules established in the Takeover Code. This notification serves as an important communication to stakeholders about recent trading activities that involve exempt principal traders...

Continue Reading
Stocks to Consider Amidst Global Market Uncertainty

Updated Category News Views 150

The Current Market Landscape As geopolitical tensions rise, markets are experiencing undercurrents of uncertainty. Recent tariff threats have sent ripples through global financial markets, particularly affecting investor confidence in stocks. The atmosphere is becoming increasingly cautious, with many investors wondering which stocks might shield their portfolios during...

Continue Reading